AKBA SG&A Expense Growth
Akebia Therapeutics Inc · SG&A Expense Growth
AKBA SG&A Expense Growth
Latest reported0.88%period ending
AKBA FY SG&A Growth (YoY) (0.00% → 0.88%)
Latest values, visible window
High-resolution chart · PNG
AKBA sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.8776% | |
| 6.2973% | |
| -27.6823% | |
| -20.4083% | |
| 13.0053% | |
| 3.1073% | |
| 71.667% | |
| 222.3526% | |
| 21.6029% | |
| 20.0735% | |
| 47.4805% | |
| 143.4574% | |
| 78.1951% | |
| 0% |